He graduated from Macau University of Science and Technology and worked at GIRS since 2006. He is a clinical virology scientist with particular interest in emerging virus disease at the animal-human interface including avian H7N9 and H5N6 influenza virus, and MERS-CoV as well as the associated viral immunology. His research interests also involve the use of pharmaceutical animal model (ie. Mice, ferrets and tree shrew) to understand the protective effect, optimized regimen and underlying mechanisms of approved drugs, novel compounds and traditional Chinese medicines against respiratory viruses.